ANTHOS
Live / Applied — Second extension granted (statement of use) (as of 01 Oct 2025)
What this means for you
Not registered yet, but its 13 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98695462
- Mark type
- Stylized text
- Filed
- 13 Aug 2024
- Published for opposition
- 15 Oct 2024
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment and prevention of cancer-associated diseases and associated disorders
Owner
- Anthos Therapeutics, Inc., Cambridge, MA, US
- Anthos Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 02 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2025 — SOU EXTENSION 2 GRANTED
- 01 Oct 2025 — SOU EXTENSION 2 FILED
- 01 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2025 — SOU EXTENSION 1 GRANTED
- 10 Apr 2025 — SOU EXTENSION 1 FILED
- 10 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2024 — PUBLISHED FOR OPPOSITION
- 25 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Sept 2024 — EXAMINER'S AMENDMENT ENTERED
- 11 Sept 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED